Neuropathic Pain Due to Diabetes Type I or Type II
Showing 1 - 25 of >10,000
Diabetic Neuropathy, Painful, Diabetes, Type 1 Trial in Aalborg (Sooma Oy (tDCS), Helsinki, Finland, Sooma Oy (Sham), Helsinki,
Recruiting
- Diabetic Neuropathy, Painful
- Diabetes Mellitus, Type 1
- Sooma Oy (tDCS), Helsinki, Finland
- Sooma Oy (Sham), Helsinki, Finland
-
Aalborg, DenmarkAalborg University Hospital
Nov 29, 2023
Diabetes, Type 2, Neuropathic Pain, Neuropathy, Diabetic Trial in Mérida (Combined Exercise)
Active, not recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Combined Exercise
-
Mérida, Yucatán, MexicoUnidad Universitaria de Inserción Social San José Tecoh
Jan 26, 2023
Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate
Active, not recruiting
- Neuropathic Pain
- Diabetes Mellitus, Type 2
- pregabalin sustained release tablet
- pregabalin immediate release capsule
-
Cheongju, Chungcheongbuk-do, Korea, Republic of
- +7 more
Nov 14, 2022
Knee Osteoarthritis, Type II Diabetes Trial in Barnala (thermotherapy+ TENS+ low intensity high repetition exercises and Buerger
Recruiting
- Knee Osteoarthritis
- Type II Diabetes
- thermotherapy+ TENS+ low intensity high repetition exercises and Buerger Allen
- thermotherapy+ TENS+ low intensity high repetition exercises
-
Barnala, Azad Kashmir, PakistanTehsil headquarter hospital
May 18, 2023
Gastroparesis Due to Diabetes Type I Trial (technetium scitigraphy)
Not yet recruiting
- Gastroparesis Due to Diabetes Mellitus Type I
- technetium scitigraphy
- (no location specified)
Feb 6, 2023
Pain, Pain Syndrome, Pain, Chronic Trial (Adezunap (AP707), Placebo)
Not yet recruiting
- Pain
- +10 more
- Adezunap (AP707)
- Placebo
- (no location specified)
Oct 5, 2023
Pain, Pain Syndrome, Pain, Chronic Trial (Adezunap (AP707), Placebo)
Not yet recruiting
- Pain
- +10 more
- Adezunap (AP707)
- Placebo
- (no location specified)
Oct 5, 2023
mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels
Completed
- Diabetes Mellitus, Type 2
- +3 more
- None (not interventional)
-
Boca Raton, FloridaEast Coast Medical Associates
Aug 15, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
Not yet recruiting
- Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
- IncobotulinumtoxinA
- Placebo
- (no location specified)
Oct 13, 2023
Peripheral Neuropathy, Pain, Neuropathic, Diabetes Trial in New York (Moxibustion - Traditional (Active), Moxibustion -
Recruiting
- Peripheral Neuropathy
- +2 more
- Moxibustion - Traditional (Active)
- +2 more
-
New York, New York
- +1 more
Feb 14, 2022
Diabetic Neuropathies, Insomnia Due to Medical Condition Trial in Mumbai (NeuropAWAY, Microcystalline cellulose)
Completed
- Diabetic Neuropathies
- Insomnia Due to Medical Condition
- NeuropAWAY
- Microcystalline cellulose
-
Mumbai, Maharashtra, India
- +1 more
Apr 6, 2021
Diabetic Foot Ulcer, Diabetes, Diabetic Foot Trial in Lahore (Control; Standard-of-care management, Only PRP injection, PRP +
Recruiting
- Diabetic Foot Ulcer
- +10 more
- Control; Standard-of-care management
- +3 more
-
Lahore, Punjab, PakistanStem Cell Laboratory, Jinnah Burn and Reconstructive Surgery Cen
Nov 3, 2022
Gestational Diabetes, Glucose Metabolism Disorders, Metabolic Disease Trial in Singapore (Wearable Care Group)
Recruiting
- Gestational Diabetes
- +2 more
- Wearable Care Group
-
Singapore, SingaporeKK Women's and Children's Hospital
Jan 30, 2023
Gastroparesis Registry 4
Not yet recruiting
- Gastroparesis
- +5 more
-
Scottsdale, Arizona
- +5 more
May 10, 2023
Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio
Completed
- Type 2 Diabetes
- Sitagliptin/metformin ( 50/500mg) Oral Tablet
- Empagliflozin/metformin(10/500mg) Oral Tablet
-
Baqubah, Diyala, IraqCollege of Medicine, University of Diyala
Apr 7, 2023
Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)
Recruiting
- Diabetes Mellitus, Type 1
- GAD-alum (Diamyd) 40 μg/mL
-
Linköping, SwedenKliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
Aug 17, 2022
Mixed Anxiety Depression, Diabetes, Type 2, Low Back Pain Trial in Øystese (Interdisciplincary concentrated group
Recruiting
- Mixed Anxiety Depression
- +4 more
- Interdisciplincary concentrated group rehabilitation
-
Øystese, NorwayHelse i Hardanger
Jul 1, 2022
Type 2 Diabetes Trial in Seoul (D745 formulation I, D745 formulation II, D745 Placebo)
Recruiting
- Type 2 Diabetes
- D745 formulation I
- +2 more
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Sep 30, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Diabetes, Type 2 Trial in Hanoi (Andiabet)
Completed
- Diabetes Mellitus, Type 2
-
Hanoi, VietnamCentre of Clinical Pharmacology, Hanoi Medical University
Jun 11, 2021
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Active, not recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +35 more
Aug 23, 2022
Foot Ulcer, Diabetic Trial (Procenta conformable barrier)
Not yet recruiting
- Foot Ulcer, Diabetic
- Procenta conformable barrier
- (no location specified)
Oct 21, 2021